Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000226045 represents a pseudogene homolog of the glutamyl-tRNA amidotransferase subunit C (GATC), but it does not code for a functional protein and is not a molecular therapeutic target. The active, protein-coding version of GATC is involved in mitochondrial translation and proper glutaminyl-tRNAGln biosynthesis, with clinical associations in mitochondrial disorders, but ENSG00000226045 itself does not have a known molecular function, role in disease, or targeting by drugs[2][1]. This entry should not be considered a valid or actionable molecular target due to its pseudogene status[2]. Pseudogenes do not have an active biological function and there is no evidence for direct disease association as this is a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamyl-tRNA amidotransferase subunit C homolog pseudogene.